应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XENE Xenon制药
交易中 07-14 13:06:49 EDT
32.95
+0.74
+2.30%
最高
33.12
最低
32.20
成交量
21.65万
今开
32.21
昨收
32.21
日振幅
2.86%
总市值
25.28亿
流通市值
23.36亿
总股本
7,673万
成交额
711.76万
换手率
0.31%
流通股本
7,088万
市净率
3.59
ROE
-31.60%
每股收益
-3.22
52周最高
46.00
52周最低
26.74
市盈率
-10.24
股息
0.00
股息收益率
0.00
ROA
-22.03%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Xenon制药盘中异动 快速上涨5.03%
市场透视 · 07-09
Xenon制药盘中异动 快速上涨5.03%
Xenon制药2025财年第一财季实现净利润-65.05百万美元,同比减少35.72%
市场透视 · 05-18
Xenon制药2025财年第一财季实现净利润-65.05百万美元,同比减少35.72%
Xenon Pharmaceuticals获Evercore ISI Group首次覆盖,给予优于大市评级, 目标价55.00美元。
金融界 · 05-14
Xenon Pharmaceuticals获Evercore ISI Group首次覆盖,给予优于大市评级, 目标价55.00美元。
富国银行:维持Xenon Pharmaceuticals(XENE.US)评级,由增持调整至增持评级, 目标价由50.00美元调整至47.00美元。
金融界 · 05-13
富国银行:维持Xenon Pharmaceuticals(XENE.US)评级,由增持调整至增持评级, 目标价由50.00美元调整至47.00美元。
加拿大皇家银行:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由58.00美元调整至55.00美元。
金融界 · 05-13
加拿大皇家银行:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由58.00美元调整至55.00美元。
Xenon制药盘中异动 早盘股价大涨5.07%报36.80美元
市场透视 · 05-12
Xenon制药盘中异动 早盘股价大涨5.07%报36.80美元
Xenon制药盘中异动 大幅上涨5.10%报36.47美元
市场透视 · 04-22
Xenon制药盘中异动 大幅上涨5.10%报36.47美元
Xenon制药盘中异动 急速跳水8.12%
市场透视 · 04-21
Xenon制药盘中异动 急速跳水8.12%
高盛:维持Xenon Pharmaceuticals评级,由买入调整至买入评级, 目标价由60.00美元调整至52.00美元。
金融界 · 04-17
高盛:维持Xenon Pharmaceuticals评级,由买入调整至买入评级, 目标价由60.00美元调整至52.00美元。
Xenon制药盘中异动 下午盘急速拉升5.13%报33.01美元
市场透视 · 04-14
Xenon制药盘中异动 下午盘急速拉升5.13%报33.01美元
Xenon制药盘中异动 大幅下跌5.00%报34.68美元
市场透视 · 03-10
Xenon制药盘中异动 大幅下跌5.00%报34.68美元
Xenon制药2024财年实现净利润-2.34亿美元,同比减少28.57%
市场透视 · 03-07
Xenon制药2024财年实现净利润-2.34亿美元,同比减少28.57%
Xenon制药盘中异动 临近收盘股价大跌5.00%报35.17美元
市场透视 · 03-03
Xenon制药盘中异动 临近收盘股价大跌5.00%报35.17美元
Xenon制药盘中异动 股价大跌6.00%报36.01美元
市场透视 · 02-28
Xenon制药盘中异动 股价大跌6.00%报36.01美元
氙气制药公司2024年第四季度GAAP每股收益$(0.84)优于$(0.86)预期
财报速递 · 02-27
氙气制药公司2024年第四季度GAAP每股收益$(0.84)优于$(0.86)预期
Xenon制药盘中异动 股价大涨5.09%报39.57美元
市场透视 · 02-26
Xenon制药盘中异动 股价大涨5.09%报39.57美元
Xenon Pharmaceuticals(XENE.US)获德银首次覆盖,给予买入评级, 目标价67.00美元。
金融界 · 02-11
Xenon Pharmaceuticals(XENE.US)获德银首次覆盖,给予买入评级, 目标价67.00美元。
Xenon制药盘中异动 早盘大幅拉升5.05%
市场透视 · 01-02
Xenon制药盘中异动 早盘大幅拉升5.05%
Xenon制药盘中异动 股价大跌5.00%报40.82美元
市场透视 · 2024-12-12
Xenon制药盘中异动 股价大跌5.00%报40.82美元
异动解读 | Xenon制药业绩亏损扩大 股价盘中大跌5.5%
异动解读 · 2024-11-18
异动解读 | Xenon制药业绩亏损扩大 股价盘中大跌5.5%
加载更多
公司概况
公司名称:
Xenon制药
所属市场:
NASDAQ
上市日期:
2014-11-05
主营业务:
Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。
发行价格:
9.00
{"stockData":{"symbol":"XENE","market":"US","secType":"STK","nameCN":"Xenon制药","latestPrice":32.95,"timestamp":1752512803551,"preClose":32.21,"halted":0,"volume":216527,"delay":0,"floatShares":70881718,"shares":76733599,"eps":-3.216743,"marketStatus":"交易中","change":0.74,"latestTime":"07-14 13:06:46 EDT","open":32.21,"high":33.12,"low":32.2,"amount":7117598.243861,"amplitude":0.028563,"askPrice":32.94,"askSize":70,"bidPrice":32.89,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.216743,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752523200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1415163600000,"exchange":"NASDAQ","adjPreClose":32.21,"postHourTrading":{"tag":"盘后","latestPrice":32.21,"preClose":32.21,"latestTime":"17:23 EDT","volume":22454,"amount":723248.84,"timestamp":1752269022057},"volumeRatio":0.466146,"impliedVol":0.4248,"impliedVolPercentile":0.452},"requestUrl":"/m/hq/s/XENE","defaultTab":"news","newsList":[{"id":"2550265605","title":"Xenon制药盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550265605?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:52","pubTimestamp":1752072749,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时52分,Xenon制药股票出现波动,股价急速拉升5.03%。截至发稿,该股报33.00美元/股,成交量18.8883万股,换手率0.25%,振幅4.23%。Xenon制药股票所在的生物技术行业中,整体涨幅为1.15%。其相关个股中,Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃,换手率分别为1127.81%、712.51%、533.03%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Prokidney Corp.,振幅分别为173.13%、112.02%、57.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225230a69fac24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225230a69fac24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2536594385","title":"Xenon制药2025财年第一财季实现净利润-65.05百万美元,同比减少35.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594385","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594385?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584048,"startTime":"0","endTime":"0","summary":"5月19日,Xenon制药公布财报,公告显示公司2025财年第一财季净利润为-65.05百万美元,同比减少35.72%;其中营业收入为7.50百万美元,每股基本收益为-0.83美元。从资产负债表来看,Xenon制药总负债39.32百万美元,其中短期债务1.38百万美元,资产负债比为0.19,流动比率为0.18。机构评级:截至2025年5月19日,当前有18家机构对Xenon制药目标价做出预测,其中目标均价为55.33美元,其中最低目标价为42.00美元,最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000233a6e3a770&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000233a6e3a770&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2535349070","title":"Xenon Pharmaceuticals获Evercore ISI Group首次覆盖,给予优于大市评级, 目标价55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535349070","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535349070?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:04","pubTimestamp":1747238685,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals(XENE.US)获Evercore ISI Group首次覆盖,给予优于大市评级, 目标价55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150010069759a360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150010069759a360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","EVR"],"gpt_icon":0},{"id":"2535085705","title":"富国银行:维持Xenon Pharmaceuticals(XENE.US)评级,由增持调整至增持评级, 目标价由50.00美元调整至47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535085705","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535085705?lang=zh_cn&edition=full","pubTime":"2025-05-14 02:41","pubTimestamp":1747161702,"startTime":"0","endTime":"0","summary":"富国银行:维持Xenon Pharmaceuticals(XENE.US)评级,由增持调整至增持评级, 目标价由50.00美元调整至47.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14024150362454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XENE"],"gpt_icon":0},{"id":"2535700005","title":"加拿大皇家银行:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由58.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535700005","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535700005?lang=zh_cn&edition=full","pubTime":"2025-05-14 01:32","pubTimestamp":1747157573,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由58.00美元调整至55.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14013250362347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XENE"],"gpt_icon":0},{"id":"2534276659","title":"Xenon制药盘中异动 早盘股价大涨5.07%报36.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534276659?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:37","pubTimestamp":1747057071,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时37分,Xenon制药股票出现异动,股价急速拉升5.07%。截至发稿,该股报36.80美元/股,成交量3.0606万股,换手率0.04%,振幅2.51%。Xenon制药股票所在的生物技术行业中,整体涨幅为2.59%。其相关个股中,Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、艾吉纳斯涨幅较大,Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为349.72%、72.64%、59.49%,振幅较大的相关个股有Cytomx Therapeutics, Inc.、艾吉纳斯、Engene Holdings Inc.,振幅分别为49.55%、29.16%、21.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221375197574580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221375197574580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2529453532","title":"Xenon制药盘中异动 大幅上涨5.10%报36.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529453532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529453532?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:54","pubTimestamp":1745340883,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时54分,Xenon制药股票出现波动,股价快速拉升5.10%。截至发稿,该股报36.47美元/股,成交量34.3358万股,换手率0.45%,振幅4.24%。Xenon制药股票所在的生物技术行业中,整体涨幅为1.99%。其相关个股中,Moolec Science Sa C/Wts 、Portage Biotech Inc.、艾吉纳斯涨幅较大,Portage Biotech Inc.、Ocean Biomedical, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为220.50%、210.08%、145.38%,振幅较大的相关个股有Scorpius Holdings, Inc.、Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为102.79%、90.00%、75.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423005443a6c40a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423005443a6c40a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2529938873","title":"Xenon制药盘中异动 急速跳水8.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529938873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529938873?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242265,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分,Xenon制药股票出现波动,股价急速下挫8.12%。Xenon制药股票所在的生物技术行业中,整体跌幅为0.32%。Xenon制药公司简介:Xenon Pharmaceuticals Inc 是一家专注于神经科学的生物制药公司,致力于改善神经和精神疾病患者的生活。消息层面,截至21时31分,《高盛:维持Xenon Pharmaceuticals评级,由买入调整至买入评级, 目标价由60.00美元调整至52.00美元。》资讯为影响Xenon制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121310594dcea94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121310594dcea94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2528724987","title":"高盛:维持Xenon Pharmaceuticals评级,由买入调整至买入评级, 目标价由60.00美元调整至52.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528724987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528724987?lang=zh_cn&edition=full","pubTime":"2025-04-18 02:04","pubTimestamp":1744913076,"startTime":"0","endTime":"0","summary":"高盛:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由60.00美元调整至52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418020641973b8b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418020641973b8b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2527110188","title":"Xenon制药盘中异动 下午盘急速拉升5.13%报33.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527110188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527110188?lang=zh_cn&edition=full","pubTime":"2025-04-15 02:46","pubTimestamp":1744656403,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日02时46分,Xenon制药股票出现异动,股价急速上涨5.13%。截至发稿,该股报33.01美元/股,成交量45.7853万股,换手率0.60%,振幅5.64%。Xenon制药股票所在的生物技术行业中,整体涨幅为2.60%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Zyversa Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大,Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为802.79%、683.07%、338.80%,振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Zyversa Therapeutics, Inc.,振幅分别为78.58%、66.92%、66.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041502464394d53969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041502464394d53969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2518063352","title":"Xenon制药盘中异动 大幅下跌5.00%报34.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518063352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518063352?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:40","pubTimestamp":1741628437,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时40分,Xenon制药股票出现异动,股价大幅下挫5.00%。截至发稿,该股报34.68美元/股,成交量15.2499万股,换手率0.20%,振幅5.75%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.83%。其相关个股中,Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为5311.24%、3824.09%、989.67%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、58.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101403796406796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101403796406796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2517082437","title":"Xenon制药2024财年实现净利润-2.34亿美元,同比减少28.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517082437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517082437?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363252,"startTime":"0","endTime":"0","summary":"3月8日,Xenon制药公布财报,公告显示公司2024财年净利润为-2.34亿美元,同比减少28.57%;其中营业收入为0.00美元,每股基本收益为-3.01美元。从资产负债表来看,Xenon制药总负债3.12亿美元,其中短期债务1.37百万美元,资产负债比为3.42,流动比率为0.18。机构评级:截至2025年3月8日,当前有16家机构对Xenon制药目标价做出预测,其中目标均价为57.81美元,其中最低目标价为42.00美元,最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2516184665","title":"Xenon制药盘中异动 临近收盘股价大跌5.00%报35.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516184665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516184665?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:49","pubTimestamp":1741034991,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时49分,Xenon制药股票出现异动,股价快速跳水5.00%。截至发稿,该股报35.17美元/股,成交量57.2635万股,换手率0.75%,振幅7.16%。机构评级方面,在所有17家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。Xenon制药股票所在的生物技术行业中,整体跌幅为0.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044951a25da8cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044951a25da8cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XENE"],"gpt_icon":0},{"id":"2514105378","title":"Xenon制药盘中异动 股价大跌6.00%报36.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514105378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514105378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753092,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分,Xenon制药股票出现波动,股价快速跳水6.00%。截至发稿,该股报36.01美元/股,成交量3487股,换手率0.00%,振幅0.00%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-62.79百万美元,每股收益-0.81美元,毛利-669000.00美元,市盈率-13.17倍。机构评级方面,在所有17家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。Xenon制药股票所在的生物技术行业中,整体涨幅为0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223132abe0ea36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223132abe0ea36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"1116368381","title":"氙气制药公司2024年第四季度GAAP每股收益$(0.84)优于$(0.86)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1116368381","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116368381?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:04","pubTimestamp":1740690277,"startTime":"0","endTime":"0","summary":"氙气制药公司报告季度亏损每股$,优于分析师共识$的预期,超出2.33%。与去年同期每股亏损$相比,这减少了31.25%。以上内容来自Benzinga Earnings专栏,原文如下:Xenon Pharmaceuticals reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.33 percent. This is a 31.25 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"氙气制药公司2024年第四季度GAAP每股收益$(0.84)优于$(0.86)预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE"],"gpt_icon":0},{"id":"2514586612","title":"Xenon制药盘中异动 股价大涨5.09%报39.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514586612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514586612?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:20","pubTimestamp":1740594023,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时20分,Xenon制药股票出现波动,股价急速拉升5.09%。截至发稿,该股报39.57美元/股,成交量27.5217万股,换手率0.36%,振幅5.30%。Xenon制药股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6430.38%、270.06%、241.41%,振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation,振幅分别为194.07%、49.18%、44.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227022024abde1f83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227022024abde1f83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2510358484","title":"Xenon Pharmaceuticals(XENE.US)获德银首次覆盖,给予买入评级, 目标价67.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358484","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510358484?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:11","pubTimestamp":1739297470,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals(XENE.US)获德银首次覆盖,给予买入评级, 目标价67.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12021148092642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XENE"],"gpt_icon":0},{"id":"2500497512","title":"Xenon制药盘中异动 早盘大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500497512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500497512?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:19","pubTimestamp":1735831166,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时19分,Xenon制药股票出现波动,股价快速上涨5.05%。截至发稿,该股报41.18美元/股,成交量6.4519万股,换手率0.08%,振幅4.41%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.96%。其相关个股中,Revelation Biosciences Inc C/Wts 10/01/2027 、知临集团、Revelation Biosciences, Inc.涨幅较大,Revelation Biosciences, Inc.、知临集团、Onconetix, Inc.较为活跃,换手率分别为1058.06%、85.94%、45.92%,振幅较大的相关个股有Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为121.48%、98.57%、78.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231926a2130dbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231926a2130dbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2491337186","title":"Xenon制药盘中异动 股价大跌5.00%报40.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491337186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491337186?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:40","pubTimestamp":1734025257,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时40分,Xenon制药股票出现波动,股价快速跳水5.00%。截至发稿,该股报40.82美元/股,成交量13.7463万股,换手率0.18%,振幅4.75%。Xenon制药股票所在的生物技术行业中,整体跌幅为1.03%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为3828.88%、922.85%、86.23%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为129.16%、99.29%、86.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014057984b9dbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014057984b9dbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XENE"],"gpt_icon":0},{"id":"1190905894","title":"异动解读 | Xenon制药业绩亏损扩大 股价盘中大跌5.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190905894","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190905894?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:10","pubTimestamp":1731957025,"startTime":"0","endTime":"0","summary":"Xenon制药(XENE.US)盘中股价大跌5.5%,引起市场广泛关注。\n\n公司于11月18日公布2024财年第三财季财报,数据显示公司当季继续亏损,净利润为-6279万美元,同比减少29.57%。虽然营收为零,但亏损金额进一步扩大,这给投资者带来较大压力,显然是导致股价下跌的主要原因。\n\n具体来看,当日Xenon制药股价盘中一度下跌5.13%至37.79美元,成交量达33.9万股,换手率0.44%。从行情走势上看,股价出现了明显下行趋势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Xenon制药业绩亏损扩大 股价盘中大跌5.5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["XENE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xenon-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":-0.0015},{"period":"3month","weight":0.0258},{"period":"6month","weight":-0.1614},{"period":"1year","weight":-0.2178},{"period":"ytd","weight":-0.1783}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.016807},{"month":2,"riseRate":0.727273,"avgChangeRate":0.078057},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.075368},{"month":4,"riseRate":0.545455,"avgChangeRate":0.022894},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.037416},{"month":6,"riseRate":0.454545,"avgChangeRate":0.032291},{"month":7,"riseRate":0.454545,"avgChangeRate":0.02398},{"month":8,"riseRate":0.7,"avgChangeRate":0.055793},{"month":9,"riseRate":0.1,"avgChangeRate":-0.068466},{"month":10,"riseRate":0.4,"avgChangeRate":0.056033},{"month":11,"riseRate":0.7,"avgChangeRate":0.048774},{"month":12,"riseRate":0.636364,"avgChangeRate":0.0977}],"exchange":"NASDAQ","name":"Xenon制药","nameEN":"Xenon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xenon制药,XENE,Xenon制药股票,Xenon制药股票老虎,Xenon制药股票老虎国际,Xenon制药行情,Xenon制药股票行情,Xenon制药股价,Xenon制药股市,Xenon制药股票价格,Xenon制药股票交易,Xenon制药股票购买,Xenon制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}